ADAGENE

Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer... Driven by a powerful platform combining computational biology and artificial intelligence, we create novel antibodies that overcome safety issues and improve efficacy to bring hope to more cancer patients. Our discovery engine, Dynamic Precision Library, is driving Adagene's pipeline of programs with potential to be first or best in class.

Primary location: San Diego United States